Australien - Englisch - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - etoricoxib, quantity: 120 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; carnauba wax; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; iron oxide yellow - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - etoricoxib, quantity: 60 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; iron oxide yellow - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flupentixol decanoate 100 mg/ml - injection (depot) - 100 mg/ml - active: flupentixol decanoate 100 mg/ml excipient: vegetable oil - fluanxol concentrated injection is a depot neuroleptic preparation and is indicated in the treatment of moderate to severe schizophrenia and allied psychoses. patients for whom the drug is especially appropriate are: 1. those believed by the physician to be unreliable in taking oral medication. 2. patients who are already receiving treatment with fluanxol injection at high dose levels and who may experience discomfort as a result of the large injection volume. 3. patients who hitherto could not receive effective treatment with depot neuroleptics because of the high doses, and hence large volumes, required to achieve satisfactory therapeutic blood levels. features of the illness most likely to benefit are hallucinations, paranoid delusions, apathy, inertia, withdrawal and anxiety

Irland - Englisch - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - lidocaine hydrochloride zinc oxide bismuth oxide benzoic acid cinnamic acid - cream - 25 grams

Malta - Englisch - Medicines Authority

boston healthcare limited unit 6, navigation court, calder park, wakefield, west yorkshire wf2 7jb, united kingdom - benzoic acid, cinnamic acid, bismuth oxide, zinc oxide, lidocaine hydrochloride - cream - benzoic acid 0.4 % (w/w) cinnamic acid 0.45 % (w/w) bismuth oxide 2 % (w/w) zinc oxide 10 % (w/w) lidocaine hydrochloride 0.65 % (w/w) - antipruritics, incl. antihistamines, anesthetics, etc.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ibuprofen, quantity: 400 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 6000; croscarmellose sodium; purified water; povidone; sodium lauryl sulfate; stearic acid; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; purified talc; hypromellose - for the temporary relief of pain and/or inflammation associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, arthritis, rheumatic pain and aches and pains associated with colds and flu. reduces fever.

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

allied animal health pty ltd - oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline hydrochloride antibiotic active 1000.0 g/kg - antibiotic & related - calf | cattle | pigs | poultry | beef | beef calf | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bu - organisms sensitive to oxytetracycline | enteric bacterial infection | respiratory infection

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

allied animal health pty ltd - chloramine - topical solution/suspension - chloramine sulfanyl active 1000.0 g/kg - dermatological preps. - animal wound or sore | cattery | dog kennel and yard | general disinfection (walls, stalls,etc) | poultry pen, roost or nest lit - cut or wound disinfection | fungicide disinfectant | general disinfection | salmonella | staphylococci | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | including b-lactamase producin | kennel | mastitis | mould growth | poultry cages | protozoans | salmonellosis | stables | toilets (not septic) | walls

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

allied animal health pty ltd - bicarbonate; glucose; chloride; potassium; sodium - oral powder, pre-mix - bicarbonate ungrouped active 290.4 g/kg; glucose carbohydrate active 100.0 g/kg; chloride mineral-chlorine active 251.4 g/kg; potassium mineral-potassium active 209.6 g/kg; sodium mineral-sodium active 148.6 g/kg - nutrition & metabolism - calf | horse | pigs | poultry | beef calf | boar | bovine | breeders | broiler | calf - poddy | calf - preweaning | calf - sucke - prevent fluid loss | electrolyte replacement

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - etoricoxib, quantity: 90 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; carnauba wax; croscarmellose sodium; titanium dioxide; lactose monohydrate; hypromellose; triacetin - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.